Yurong Guo

Yurong Guo

Company: Arcturus Therapeutics

Job title: Director, Analytical Development


Seminar: Analytical Method Development in mRNA-Lipid Nanoparticle COVID-19 Replicon Vaccines

  • Challenges and overall strategy in developing and transferring analytical methods for
    mRNA-lipid nanoparticle COVID-19 replicon vaccines
  • Analytical method development for content of mRNA in mRNA-lipid nanoparticle
  • Analytical method development for purity of mRNA in drug substance and mRNA-lipid
    nanoparticle – from AGE to CE

Day: Pre-Conference Focus Day

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.